tiprankstipranks
Trending News
More News >
Surgical Science Sweden AB (SE:SUS)
:SUS
Sweden Market
Advertisement

Surgical Science Sweden AB (SUS) Ratios

Compare
1 Followers

Surgical Science Sweden AB Ratios

SE:SUS's free cash flow for Q1 2025 was kr0.69. For the 2025 fiscal year, SE:SUS's free cash flow was decreased by kr and operating cash flow was kr0.10. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
3.89 4.22 2.70 2.65 4.26
Quick Ratio
3.23 3.56 2.26 2.17 3.87
Cash Ratio
2.15 2.70 1.42 1.36 2.79
Solvency Ratio
0.44 0.81 0.56 0.29 0.57
Operating Cash Flow Ratio
0.36 1.01 0.42 0.17 0.74
Short-Term Operating Cash Flow Coverage
63.13 0.00 0.00 0.00 0.00
Net Current Asset Value
kr 688.96Mkr 633.73Mkr 413.26Mkr 223.85Mkr 88.17M
Leverage Ratios
Debt-to-Assets Ratio
<0.01 <0.01 <0.01 <0.01 <0.01
Debt-to-Equity Ratio
<0.01 <0.01 <0.01 <0.01 <0.01
Debt-to-Capital Ratio
<0.01 <0.01 <0.01 <0.01 <0.01
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
1.09 1.08 1.10 1.11 1.11
Debt Service Coverage Ratio
100.04 442.44 192.41 5.90 83.08
Interest Coverage Ratio
0.00 288.34 124.55 3.87 63.41
Debt to Market Cap
<0.01 0.00 0.00 0.00 0.00
Interest Debt Per Share
0.03 0.80 0.31 0.82 0.08
Net Debt to EBITDA
-3.06 -1.83 -1.54 -2.65 -2.81
Profitability Margins
Gross Profit Margin
66.90%69.42%66.23%72.51%84.32%
EBIT Margin
15.49%30.46%28.37%24.20%19.06%
EBITDA Margin
21.11%36.76%33.80%31.37%28.84%
Operating Profit Margin
15.03%21.43%20.25%24.20%19.06%
Pretax Profit Margin
18.64%30.39%25.94%17.94%18.76%
Net Profit Margin
14.91%26.50%23.42%23.52%14.89%
Continuous Operations Profit Margin
14.91%26.50%23.42%23.52%14.89%
Net Income Per EBT
79.95%87.22%90.30%131.07%79.38%
EBT Per EBIT
124.02%141.82%128.08%74.14%98.42%
Return on Assets (ROA)
2.88%4.98%4.04%2.17%3.30%
Return on Equity (ROE)
3.08%5.38%4.44%2.41%3.65%
Return on Capital Employed (ROCE)
3.09%4.23%3.74%2.37%4.53%
Return on Invested Capital (ROIC)
2.47%3.69%3.38%3.11%3.60%
Return on Tangible Assets
11.35%21.52%20.79%12.59%10.48%
Earnings Yield
1.80%2.52%2.25%0.72%0.49%
Efficiency Ratios
Receivables Turnover
4.62 7.98 3.29 2.04 3.27
Payables Turnover
0.00 6.54 4.13 2.93 7.13
Inventory Turnover
1.67 1.75 2.01 0.89 1.32
Fixed Asset Turnover
8.49 11.52 15.63 9.55 12.26
Asset Turnover
0.19 0.19 0.17 0.09 0.22
Working Capital Turnover Ratio
1.09 1.38 1.77 1.51 1.20
Cash Conversion Cycle
297.92 198.72 204.21 463.93 337.24
Days of Sales Outstanding
79.03 45.73 111.03 178.92 111.71
Days of Inventory Outstanding
218.89 208.81 181.65 409.42 276.70
Days of Payables Outstanding
0.00 55.82 88.47 124.40 51.17
Operating Cycle
297.92 254.54 292.68 588.34 388.41
Cash Flow Ratios
Operating Cash Flow Per Share
2.03 4.68 2.55 0.92 0.68
Free Cash Flow Per Share
1.10 3.81 1.87 0.58 0.42
CapEx Per Share
0.94 0.87 0.68 0.34 0.25
Free Cash Flow to Operating Cash Flow
0.54 0.81 0.73 0.63 0.63
Dividend Paid and CapEx Coverage Ratio
2.17 5.40 3.75 2.72 2.67
Capital Expenditure Coverage Ratio
2.17 5.40 3.75 2.72 2.67
Operating Cash Flow Coverage Ratio
63.13 5.95 8.82 3.24 10.01
Operating Cash Flow to Sales Ratio
0.11 0.27 0.16 0.11 0.22
Free Cash Flow Yield
0.71%2.09%1.13%0.21%0.45%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
55.62 39.73 44.51 138.68 205.92
Price-to-Sales (P/S) Ratio
8.29 10.53 10.43 32.61 30.66
Price-to-Book (P/B) Ratio
1.75 2.14 1.97 3.34 7.53
Price-to-Free Cash Flow (P/FCF) Ratio
140.26 47.87 88.13 484.11 221.16
Price-to-Operating Cash Flow Ratio
75.62 39.01 64.62 306.03 138.37
Price-to-Earnings Growth (PEG) Ratio
7.97 1.65 0.54 0.39 0.00
Price-to-Fair Value
1.75 2.14 1.97 3.34 7.53
Enterprise Value Multiple
36.21 26.81 29.30 101.31 103.52
Enterprise Value
7.24B 8.70B 7.95B 11.66B 3.13B
EV to EBITDA
36.21 26.81 29.30 101.31 103.52
EV to Sales
7.65 9.85 9.90 31.78 29.86
EV to Free Cash Flow
129.33 44.81 83.72 471.78 215.32
EV to Operating Cash Flow
69.73 36.51 61.38 298.23 134.72
Tangible Book Value Per Share
16.13 14.33 9.67 6.87 3.02
Shareholders’ Equity Per Share
87.73 85.32 83.39 84.38 12.42
Tax and Other Ratios
Effective Tax Rate
0.20 0.13 0.10 -0.31 0.21
Revenue Per Share
18.55 17.33 15.80 8.63 3.05
Net Income Per Share
2.77 4.59 3.70 2.03 0.45
Tax Burden
0.80 0.87 0.90 1.31 0.79
Interest Burden
1.20 1.00 0.91 0.74 0.98
Research & Development to Revenue
0.22 0.21 0.22 0.18 0.16
SG&A to Revenue
0.11 0.08 0.08 0.18 0.13
Stock-Based Compensation to Revenue
0.00 0.00 0.00 0.00 0.00
Income Quality
0.79 1.02 0.80 0.69 1.16
Currency in SEK
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis